CimCure (private company)
See something wrong or missing? Let us know
Offices:Amsterdam
Industry:BiotechHealth servicesPharma
Business model:B2B
CimCure is a Dutch biotech startup developing vaccine-based cancer immunotherapy.
Investors:
we tracked 2 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 5.36M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to CimCure
Name | Criteria | |
---|---|---|
![]() |
Octarine Bio
68%
|
|
![]() |
PEP-Therapy
68%
|
|
![]() |
Pila Pharma
65%
|
|
![]() |
Vaxxel
65%
|
|
![]() |
Cinclus Pharma
63%
|
|
![]() |
Causaly
63%
|
|
![]() |
Kither Biotech
63%
|
|
![]() |
iCellate
60%
|
|
![]() |
ITBMed
60%
|
|
![]() |
AbolerIS Pharma
58%
|
|